Brain-Targeted Intranasal Delivery of Protein-Based Gene Therapy for Treatment of Ischemic Stroke

    January 2024 in “ Theranostics
    Jee‐Yeon Ryu, Christian D. Cerecedo-Lopez, Hongkuan Yang, Ilhwan Ryu, Rose Du
    Image
    Studysummary In this study involving a mouse model, researchers reported that intranasal delivery of protein-based CRISPR/dCas9 nanoparticles targeting the gene *Sirt1* reduced cerebral edema and increased survival following ischemic stroke, with no significant toxicity observed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →